673 — China Health Income Statement
0.000.00%
Last trade - 00:00- HK$883.83m
- HK$897.04m
- HK$38.94m
Annual income statement for China Health, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 87.9 | 107 | 76.4 | 59.9 | 38.9 |
| Cost of Revenue | |||||
| Gross Profit | 26 | 28.7 | 27.2 | 13.6 | 9.23 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 92.9 | 115 | 110 | 102 | 106 |
| Operating Profit | -5.04 | -8.42 | -33.2 | -42 | -67.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -5.33 | -8.71 | -39.4 | -42.3 | -67.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.56 | -9.11 | -39.6 | -42.5 | -67.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.74 | -12.2 | -42 | -40.2 | -67.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.74 | -12.2 | -42 | -40.2 | -67.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.019 | -0.03 | -0.099 | -0.069 | -0.098 |